BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Michalska-Kasiczak M, Sahebkar A, Mikhailidis DP, Rysz J, Muntner P, Toth PP, Jones SR, Rizzo M, Kees Hovingh G, Farnier M, Moriarty PM, Bittner VA, Lip GY, Banach M; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. Analysis of vitamin D levels in patients with and without statin-associated myalgia - a systematic review and meta-analysis of 7 studies with 2420 patients. Int J Cardiol 2015;178:111-6. [PMID: 25464233 DOI: 10.1016/j.ijcard.2014.10.118] [Cited by in Crossref: 123] [Cited by in F6Publishing: 139] [Article Influence: 15.4] [Reference Citation Analysis]
Number Citing Articles
1 Hlatky MA, Gonzalez PE, Manson JE, Buring JE, Lee I, Cook NR, Mora S, Bubes V, Stone NJ. Statin-Associated Muscle Symptoms Among New Statin Users Randomly Assigned to Vitamin D or Placebo. JAMA Cardiol 2022. [DOI: 10.1001/jamacardio.2022.4250] [Reference Citation Analysis]
2 Carallo C, Capozza A, Gnasso A. Effects of Vitamin D Supplementation in Patients with Statin-Associated Muscle Symptoms and Low Vitamin D Levels. Metabolic Syndrome and Related Disorders 2022. [DOI: 10.1089/met.2021.0127] [Reference Citation Analysis]
3 Jiang X, Zhou R, He Y, Zhu T, Zhang W. Causal effect of serum 25-hydroxyvitamin D levels on low back pain: A two-sample mendelian randomization study. Front Genet 2022;13:1001265. [DOI: 10.3389/fgene.2022.1001265] [Reference Citation Analysis]
4 Warden BA, Guyton JR, Kovacs AC, Durham JA, Jones LK, Dixon DL, Jacobson TA, Duell PB. Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association. J Clin Lipidol 2022:S1933-2874(22)00245-8. [PMID: 36115813 DOI: 10.1016/j.jacl.2022.09.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Banach M. Statin Intolerance-We Know Everything, We Know Nothing. J Clin Med 2022;11:5250. [PMID: 36079180 DOI: 10.3390/jcm11175250] [Reference Citation Analysis]
6 Penson PE, Bruckert E, Marais D, Reiner Ž, Pirro M, Sahebkar A, Bajraktari G, Mirrakhimov E, Rizzo M, Mikhailidis DP, Sachinidis A, Gaita D, Latkovskis G, Mazidi M, Toth PP, Pella D, Alnouri F, Postadzhiyan A, Yeh H, Mancini GJ, von Haehling S, Banach M, Acosta J, Al‐khnifsawi M, Alnouri F, Amar F, Atanasov AG, Bajraktari G, Banach M, Bhaskar S, Bytyçi I, Bjelakovic B, Bruckert E, Cafferata A, Ceska R, Cicero AF, Collet X, Daccord M, Descamps O, Djuric D, Durst R, Ezhov MV, Fras Z, Gaita D, Hernandez AV, Jones SR, Jozwiak J, Kakauridze N, Kallel A, Katsiki N, Khera A, Kostner K, Kubilius R, Latkovskis G, Mancini GJ, Marais AD, Martin SS, Martinez JA, Mazidi M, Mikhailidis DP, Mirrakhimov E, Miserez AR, Mitchenko O, Mitkovskaya NP, Moriarty PM, Nabavi SM, Nair D, Panagiotakos DB, Paragh G, Pella D, Penson PE, Petrulioniene Z, Pirro M, Postadzhiyan A, Puri R, Reda A, Reiner Ž, Radenkovic D, Rakowski M, Riadh J, Richter D, Rizzo M, Ruscica M, Sahebkar A, Sattar N, Serban M, Shehab AM, Shek AB, Sirtori CR, Stefanutti C, Tomasik T, Toth PP, Viigimaa M, Valdivielso P, Vinereanu D, Vohnout B, von Haehling S, Vrablik M, Wong ND, Yeh H, Zhisheng J, Zirlik A; International Lipid Expert Panel (ILEP). Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP). J cachexia sarcopenia muscle 2022;13:1596-622. [DOI: 10.1002/jcsm.12960] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
7 Shostak NA, Klimenko AA, Demidova NA, Kondrashov AA, Andryashkina DY, Saakyan YM, Varaksin GA, Tarantina AY. Musculoskeletal manifectations of the new coronavirus infection: focus on arthralgia and myalgia. Klinicist 2022;15:31-41. [DOI: 10.17650/1818-8338-2021-15-1-4-k650] [Reference Citation Analysis]
8 Zarrati M, Sohouli MH, Aleayyub S, Keshavarz N, Razmpoosh E, Găman M, Fatahi S, Heydari H. The Effect of Vitamin D Supplementation on Treatment-Induced Pain in Cancer Patients: A Systematic Review. Pain Management Nursing 2022. [DOI: 10.1016/j.pmn.2022.02.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Hou Q, Pang C, Chen Y. Association Between Vitamin D and Statin-Related Myopathy: A Meta-analysis. Am J Cardiovasc Drugs 2022;22:183-93. [PMID: 34296397 DOI: 10.1007/s40256-021-00492-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
10 Peng J, Yang G, Huang Z. Vitamin D Deficiency Impacts Exposure and Response of Pravastatin in Male Rats by Altering Hepatic OATPs. Front Pharmacol 2022;13:841954. [DOI: 10.3389/fphar.2022.841954] [Reference Citation Analysis]
11 Malaguarnera M. Biomarkers of statin-induced musculoskeletal pain: Vitamin D and beyond. Features and Assessments of Pain, Anaesthesia, and Analgesia 2022. [DOI: 10.1016/b978-0-12-818988-7.00015-7] [Reference Citation Analysis]
12 Regueras E, Torres LM, Velazquez I. Efectos pleiotrópicos de la Vitamina D en dolor: revisión de mecanismo de acción y evidencia de eficacia en dolor crónico. MPJ 2022. [DOI: 10.20986/mpj.2022.1032/2022] [Reference Citation Analysis]
13 Banach M, Burchardt P, Chlebus K, Dobrowolski P, Dudek D, Dyrbuś K, Gąsior M, Jankowski P, Jóźwiak J, Kłosiewicz-Latoszek L, Kowalska I, Małecki M, Prejbisz A, Rakowski M, Rysz J, Solnica B, Sitkiewicz D, Sygitowicz G, Sypniewska G, Tomasik T, Windak A, Zozulińska-Ziółkiewicz D, Cybulska B. PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021. Arch Med Sci 2021;17:1447-547. [PMID: 34900032 DOI: 10.5114/aoms/141941] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 13.0] [Reference Citation Analysis]
14 Banach M, Burchardt P, Chlebus K, Dobrowolski P, Dudek D, Dyrbuś K, Gąsior M, Jankowski P, Jóźwiak J, Kłosiewicz-latoszek L, Kowalska I, Małecki M, Prejbisz A, Rakowski M, Rysz J, Solnica B, Sitkiewicz D, Sygitowicz G, Sypniewska G, Tomasik T, Windak A, Zozulińska-ziółkiewicz D, Cybulska B. 2021 PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on the diagnosis and therapy of lipid disorders in Poland. diagn lab 2021;57:1-99. [DOI: 10.5604/01.3001.0015.4805] [Reference Citation Analysis]
15 Vinci P, Panizon E, Tosoni LM, Cerrato C, Pellicori F, Mearelli F, Biasinutto C, Fiotti N, Di Girolamo FG, Biolo G. Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy. Int J Mol Sci 2021;22:11687. [PMID: 34769118 DOI: 10.3390/ijms222111687] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
16 Toth PP. That Myalgia of Yours Is Not From Statin Intolerance. J Am Coll Cardiol 2021;78:1223-6. [PMID: 34531022 DOI: 10.1016/j.jacc.2021.07.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Wakeman M. A Literature Review of the Potential Impact of Medication on Vitamin D Status. Risk Manag Healthc Policy 2021;14:3357-81. [PMID: 34421316 DOI: 10.2147/RMHP.S316897] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
18 Warren T, McAllister R, Morgan A, Rai TS, McGilligan V, Ennis M, Page C, Kelly C, Peace A, Corfe BM, Mc Auley M, Watterson S. The Interdependency and Co-Regulation of the Vitamin D and Cholesterol Metabolism. Cells 2021;10:2007. [PMID: 34440777 DOI: 10.3390/cells10082007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
19 Ganji R, Sa’dinpour A, Seyedian SM, Hesam S, Afshari N, Sahebnasagh A. Comparison of Oral and Injectable Dosage Forms of Vitamin D3 on Resolving Statin-Induced Myopathy: Single Blinded Randomized Controlled Clinical Trial. SN Compr Clin Med 2021;3:1555-1560. [DOI: 10.1007/s42399-021-00906-3] [Reference Citation Analysis]
20 Diaconu CC, Iorga RA, Furtunescu F, Katsiki N, Stoian AP, Rizzo M. Statin intolerance: new data and further options for treatment. Curr Opin Cardiol 2021;36:487-93. [PMID: 33929368 DOI: 10.1097/HCO.0000000000000874] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
21 Scragg R, Sluyter JD. Is There Proof of Extraskeletal Benefits From Vitamin D Supplementation From Recent Mega Trials of Vitamin D? JBMR Plus 2021;5:e10459. [PMID: 33553994 DOI: 10.1002/jbm4.10459] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
22 Avram VF, Chamkha I, Åsander-Frostner E, Ehinger JK, Timar RZ, Hansson MJ, Muntean DM, Elmér E. Cell-Permeable Succinate Rescues Mitochondrial Respiration in Cellular Models of Statin Toxicity. Int J Mol Sci 2021;22:E424. [PMID: 33401621 DOI: 10.3390/ijms22010424] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
23 Compton ALP, Pepin MJ, Katzenberger DR, Kemp DW, Brown JN. Vitamin D Supplementation During Statin Rechallenge in Patients With a History of Intolerance. Ann Pharmacother 2021;55:814-5. [PMID: 33054316 DOI: 10.1177/1060028020966546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Mizus MC, Tiniakou E. Lipid-lowering Therapies in Myositis. Curr Rheumatol Rep 2020;22:70. [PMID: 32845379 DOI: 10.1007/s11926-020-00942-3] [Reference Citation Analysis]
25 Crisan E, Patil VK. Neuromuscular Complications of Statin Therapy. Curr Neurol Neurosci Rep 2020;20. [DOI: 10.1007/s11910-020-01064-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
26 Осочук С, Яковлева О. Features of Bone Mineralization in Combined Use of Atorvastatin and α-Calcidol (Experimental Study). Лабораторная диагностика. Восточная Европа 2020. [DOI: 10.34883/pi.2020.9.1.029] [Reference Citation Analysis]
27 Nikolic D, Banach M, Chianetta R, Luzzu LM, Pantea Stoian A, Diaconu CC, Citarrella R, Montalto G, Rizzo M. An overview of statin-induced myopathy and perspectives for the future. Expert Opin Drug Saf 2020;19:601-15. [PMID: 32233708 DOI: 10.1080/14740338.2020.1747431] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
28 Schweitzer AM, Gingrich MA, Hawke TJ, Rebalka IA. The impact of statins on physical activity and exercise capacity: an overview of the evidence, mechanisms, and recommendations. Eur J Appl Physiol 2020;120:1205-25. [PMID: 32248287 DOI: 10.1007/s00421-020-04360-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Katsiki N, Mikhailidis DP, Bajraktari G, Miserez AR, Cicero AFG, Bruckert E, Serban MC, Mirrakhimov E, Alnouri F, Reiner Ž, Paragh G, Sahebkar A, Banach M; International Lipid Expert Panel (ILEP). Statin therapy in athletes and patients performing regular intense exercise - Position paper from the International Lipid Expert Panel (ILEP). Pharmacol Res 2020;155:104719. [PMID: 32087236 DOI: 10.1016/j.phrs.2020.104719] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
30 Toth PP. Statin-Associated Muscle Symptoms Are Real. In: Thompson PD, Taylor BA, editors. Statin-Associated Muscle Symptoms. Cham: Springer International Publishing; 2020. pp. 5-19. [DOI: 10.1007/978-3-030-33304-1_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Peng J, Liu Y, Xie J, Yang G, Huang Z. Effects of vitamin D on drugs: Response and disposal. Nutrition 2020;74:110734. [PMID: 32179384 DOI: 10.1016/j.nut.2020.110734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
32 Bartlomiejczyk MA, Penson P, Banach M. Vitamin D and SAMS. Contemporary Cardiology 2020. [DOI: 10.1007/978-3-030-33304-1_14] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Taylor BA, Thompson PD. Introduction. Contemporary Cardiology 2020. [DOI: 10.1007/978-3-030-33304-1_1] [Reference Citation Analysis]
34 Mancini GBJ, Bergeron J, Fitchett D, Genest J, Gupta M, Hegele RA, Ng D, Pearson GJ, Pope J. The Canadian Consensus Working Group’s Approach to Identifying and Managing Statin-Associated Muscle and Other Symptoms. Contemporary Cardiology 2020. [DOI: 10.1007/978-3-030-33304-1_16] [Reference Citation Analysis]
35 Clark KEN, Isenberg DA. Clinical Features of Myositis: Arthritis, Raynaud Phenomenon, Constitutional. Managing Myositis 2020. [DOI: 10.1007/978-3-030-15820-0_9] [Reference Citation Analysis]
36 Marrs JC, Kostoff MD. The Clinical and Financial Cost of SAMS. Contemporary Cardiology 2020. [DOI: 10.1007/978-3-030-33304-1_17] [Reference Citation Analysis]
37 Turner RM, Pirmohamed M. Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components. J Clin Med 2019;9:E22. [PMID: 31861911 DOI: 10.3390/jcm9010022] [Cited by in Crossref: 84] [Cited by in F6Publishing: 90] [Article Influence: 28.0] [Reference Citation Analysis]
38 Newman CB, Preiss D, Tobert JA, Jacobson TA, Page RL 2nd, Goldstein LB, Chin C, Tannock LR, Miller M, Raghuveer G, Duell PB, Brinton EA, Pollak A, Braun LT, Welty FK; American Heart Association Clinical Lipidology, Lipoprotein, Metabolism and Thrombosis Committee, a Joint Committee of the Council on Atherosclerosis, Thrombosis and Vascular Biology and Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; and Stroke Council. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol 2019;39:e38-81. [PMID: 30580575 DOI: 10.1161/ATV.0000000000000073] [Cited by in Crossref: 273] [Cited by in F6Publishing: 298] [Article Influence: 91.0] [Reference Citation Analysis]
39 Scragg R. The Vitamin D Assessment (ViDA) study - Design and main findings. J Steroid Biochem Mol Biol 2020;198:105562. [PMID: 31809866 DOI: 10.1016/j.jsbmb.2019.105562] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
40 Janssen L, Allard NAE, Saris CGJ, Keijer J, Hopman MTE, Timmers S. Muscle Toxicity of Drugs: When Drugs Turn Physiology into Pathophysiology. Physiol Rev 2020;100:633-72. [PMID: 31751166 DOI: 10.1152/physrev.00002.2019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
41 Ward NC, Watts GF, Eckel RH. Statin Toxicity. Circ Res 2019;124:328-50. [PMID: 30653440 DOI: 10.1161/CIRCRESAHA.118.312782] [Cited by in Crossref: 259] [Cited by in F6Publishing: 275] [Article Influence: 86.3] [Reference Citation Analysis]
42 Manzo C. If something looks like an apple, is it necessarily an apple? - reflections on so-called "statin-induced polymyalgia rheumatica". Reumatologia 2019;57:163-6. [PMID: 31462832 DOI: 10.5114/reum.2019.86427] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
43 Banach M, Patti AM, Giglio RV, Cicero AFG, Atanasov AG, Bajraktari G, Bruckert E, Descamps O, Djuric DM, Ezhov M, Fras Z, von Haehling S, Katsiki N, Langlois M, Latkovskis G, Mancini GBJ, Mikhailidis DP, Mitchenko O, Moriarty PM, Muntner P, Nikolic D, Panagiotakos DB, Paragh G, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Rosano GMC, Rosenson RS, Rysz J, Sahebkar A, Serban MC, Vinereanu D, Vrablík M, Watts GF, Wong ND, Rizzo M; International Lipid Expert Panel (ILEP). The Role of Nutraceuticals in Statin Intolerant Patients. J Am Coll Cardiol 2018;72:96-118. [PMID: 29957236 DOI: 10.1016/j.jacc.2018.04.040] [Cited by in Crossref: 170] [Cited by in F6Publishing: 180] [Article Influence: 56.7] [Reference Citation Analysis]
44 Pryor JB, Weber BR, Weber JV, Lockridge JB, Olyaei AJ. Lipid-lowering agents for the treatment of hyperlipidemia in patients with chronic kidney disease and end-stage renal disease on dialysis: a review. Drugs Ther Perspect 2019;35:431-41. [DOI: 10.1007/s40267-019-00646-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
45 Scragg RKR. Overview of results from the Vitamin D Assessment (ViDA) study. J Endocrinol Invest 2019;42:1391-9. [DOI: 10.1007/s40618-019-01056-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
46 Archontogeorgis K, Papanas N, Rizos EC, Nena E, Zissimopoulos A, Tsigalou C, Voulgaris A, Mikhailidis DP, Elisaf MS, Froudarakis ME, Steiropoulos P. Reduced Serum Vitamin D Levels Are Associated with Insulin Resistance in Patients with Obstructive Sleep Apnea Syndrome. Medicina (Kaunas) 2019;55:E174. [PMID: 31137600 DOI: 10.3390/medicina55050174] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
47 Pennisi M, Di Bartolo G, Malaguarnera G, Bella R, Lanza G, Malaguarnera M. Vitamin D Serum Levels in Patients with Statin-Induced Musculoskeletal Pain. Dis Markers 2019;2019:3549402. [PMID: 31019583 DOI: 10.1155/2019/3549402] [Reference Citation Analysis]
48 Pennisi M, Di Bartolo G, Malaguarnera G, Bella R, Lanza G, Malaguarnera M. Vitamin D Serum Levels in Patients with Statin-Induced Musculoskeletal Pain. Dis Markers 2019;2019:3549402. [PMID: 31019583 DOI: 10.1155/2019/3549402] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
49 Taylor BA, Thompson PD. Statin-Associated Muscle Disease: Advances in Diagnosis and Management. Neurotherapeutics 2018;15:1006-17. [PMID: 30251222 DOI: 10.1007/s13311-018-0670-z] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
50 Alonso R, Cuevas A, Cafferata A. Diagnosis and Management of Statin Intolerance. J Atheroscler Thromb 2019;26:207-15. [PMID: 30662020 DOI: 10.5551/jat.RV17030] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 11.7] [Reference Citation Analysis]
51 Li X, Xiao H, Lin C, Sun W, Wu T, Wang J, Chen B, Chen X, Cheng D. Synergistic effects of liposomes encapsulating atorvastatin calcium and curcumin and targeting dysfunctional endothelial cells in reducing atherosclerosis. Int J Nanomedicine 2019;14:649-65. [PMID: 30697048 DOI: 10.2147/IJN.S189819] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 11.0] [Reference Citation Analysis]
52 Gröber U, Schmidt J, Kisters K. Important drug-micronutrient interactions: A selection for clinical practice. Crit Rev Food Sci Nutr 2020;60:257-75. [PMID: 30580552 DOI: 10.1080/10408398.2018.1522613] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
53 Chien SC, Chen PS, Huang YH, Tang SC, Li YH, Yeh HI. 2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance. J Formos Med Assoc 2019;118:1385-92. [PMID: 30584005 DOI: 10.1016/j.jfma.2018.11.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
54 Sahebkar A, Banach M. Response letter: Management of statin-induced myopathies: Much demands and still (almost) empty hands! J Cachexia Sarcopenia Muscle 2017;8:514-5. [PMID: 28631417 DOI: 10.1002/jcsm.12215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
55 Katsiki N, Mikhailidis DP. Lipids: a personal view of the past decade. Hormones 2018;17:461-78. [DOI: 10.1007/s42000-018-0058-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
56 Forouzanfar F, Butler AE, Banach M, Barreto GE, Sahbekar A. Modulation of heat shock proteins by statins. Pharmacological Research 2018;134:134-44. [DOI: 10.1016/j.phrs.2018.06.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
57 Zaleski AL, Taylor BA, Thompson PD. Coenzyme Q10 as Treatment for Statin-Associated Muscle Symptoms-A Good Idea, but…. Adv Nutr 2018;9:519S-23S. [PMID: 30032220 DOI: 10.1093/advances/nmy010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
58 Rosenson RS. Trial designs for statin muscle intolerance. Curr Opin Lipidol 2017;28:488-94. [PMID: 28832369 DOI: 10.1097/MOL.0000000000000454] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
59 Taylor BA, Panza G, Ballard KD, White CM, Thompson PD. Creatine supplementation does not alter the creatine kinase response to eccentric exercise in healthy adults on atorvastatin. J Clin Lipidol 2018;12:1305-12. [PMID: 29945780 DOI: 10.1016/j.jacl.2018.05.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
60 Toth PP, Patti AM, Giglio RV, Nikolic D, Castellino G, Rizzo M, Banach M. Management of Statin Intolerance in 2018: Still More Questions Than Answers. Am J Cardiovasc Drugs 2018;18:157-73. [PMID: 29318532 DOI: 10.1007/s40256-017-0259-7] [Cited by in Crossref: 91] [Cited by in F6Publishing: 100] [Article Influence: 22.8] [Reference Citation Analysis]
61 Imga NN, Karci AC, Oztas D, Berker D, Guler S. Effects of vitamin D supplementation on insulin resistance and dyslipidemia in overweight and obese premenopausal women. Arch Med Sci 2019;15:598-606. [PMID: 31110524 DOI: 10.5114/aoms.2018.75864] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
62 Trehan N, Afonso L, Levine DL, Levy PD. Vitamin D Deficiency, Supplementation, and Cardiovascular Health. Crit Pathw Cardiol 2017;16:109-18. [PMID: 28742648 DOI: 10.1097/HPC.0000000000000122] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
63 Wu Z, Camargo CA Jr, Khaw KT, Waayer D, Lawes CMM, Toop L, Scragg R. Effects of vitamin D supplementation on adherence to and persistence with long-term statin therapy: Secondary analysis from the randomized, double-blind, placebo-controlled ViDA study. Atherosclerosis 2018;273:59-66. [PMID: 29684661 DOI: 10.1016/j.atherosclerosis.2018.04.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
64 Taylor BA. Does Coenzyme Q10 Supplementation Mitigate Statin-Associated Muscle Symptoms? Pharmacological and Methodological Considerations. Am J Cardiovasc Drugs 2018;18:75-82. [PMID: 29027135 DOI: 10.1007/s40256-017-0251-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
65 Wu Z, Malihi Z, Stewart AW, Lawes CM, Scragg R. The association between vitamin D concentration and pain: a systematic review and meta-analysis. Public Health Nutr 2018;21:2022-37. [DOI: 10.1017/s1368980018000551] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 9.0] [Reference Citation Analysis]
66 Cicero AFG, Colletti A, Bajraktari G, Descamps O, Djuric DM, Ezhov M, Fras Z, Katsiki N, Langlois M, Latkovskis G, Panagiotakos DB, Paragh G, Mikhailidis DP, Mitchenko O, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Ray KK, Rizzo M, Sahebkar A, Serban MC, Sperling LS, Toth PP, Vinereanu D, Vrablík M, Wong ND, Banach M. Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Nutr Rev 2017;75:731-67. [PMID: 28938795 DOI: 10.1093/nutrit/nux047] [Cited by in Crossref: 191] [Cited by in F6Publishing: 194] [Article Influence: 47.8] [Reference Citation Analysis]
67 Grübler MR, März W, Pilz S, Grammer TB, Trummer C, Müllner C, Schwetz V, Pandis M, Verheyen N, Tomaschitz A, Fiordelisi A, Laudisio D, Cipolletta E, Iaccarino G. Vitamin-D concentrations, cardiovascular risk and events - a review of epidemiological evidence. Rev Endocr Metab Disord 2017;18:259-72. [PMID: 28451877 DOI: 10.1007/s11154-017-9417-0] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 12.3] [Reference Citation Analysis]
68 Wu Z, Camargo CA, Malihi Z, Bartley J, Waayer D, Lawes CM, Toop L, Khaw K, Scragg R. Monthly vitamin D supplementation, pain, and pattern of analgesic prescription: secondary analysis from the randomized, double-blind, placebo-controlled Vitamin D Assessment study. Pain 2018;159:1074-82. [DOI: 10.1097/j.pain.0000000000001189] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
69 Banach M, Mikhailidis DP. Statin Intolerance: Some Practical Hints. Cardiol Clin 2018;36:225-31. [PMID: 29609752 DOI: 10.1016/j.ccl.2017.12.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 6.3] [Reference Citation Analysis]
70 Kalra S, Priya G. Lipocrinology - the relationship between lipids and endocrine function. Drugs Context 2018;7:212514. [PMID: 29410685 DOI: 10.7573/dic.212514] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
71 Katsiki N, Kolovou G, Perez-Martinez P, Mikhailidis DP. Dyslipidaemia in the elderly: to treat or not to treat? Expert Rev Clin Pharmacol 2018;11:259-78. [PMID: 29303009 DOI: 10.1080/17512433.2018.1425138] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
72 Almurdhi MM, Reeves ND, Bowling FL, Boulton AJ, Jeziorska M, Malik RA. Response to Comment on Almurdhi et al. Reduced Lower-Limb Muscle Strength and Volume in Patients With Type 2 Diabetes in Relation to Neuropathy, Intramuscular Fat, and Vitamin D Levels. Diabetes Care 2016;39:441-447. Diabetes Care 2016;39:e184-5. [PMID: 27660129 DOI: 10.2337/dci16-0020] [Reference Citation Analysis]
73 Pilz S. Vitamin D, Cardiovascular Disease, and Hypertension. Vitamin D 2018. [DOI: 10.1016/b978-0-12-809963-6.00111-5] [Reference Citation Analysis]
74 Bader B, Schwartz RG. Primary and Secondary Prevention of Cardiovascular Disease. Cardiology Consult Manual 2018. [DOI: 10.1007/978-3-319-89725-7_4] [Reference Citation Analysis]
75 Riaz R, Merchant AZ, Ul Haq MS, Nasir SAR, Rizvi Y, Khan JA, Zakaria SM, Jawed H, Hamid K, Zehra NU, Ahmed M, Ali HA, Fatima K. Statins everyday versus alternate days: Is there a difference in myalgia rates? Indian Heart J 2018;70:492-6. [PMID: 30170642 DOI: 10.1016/j.ihj.2017.10.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
76 Ursoniu S, Sahebkar A, Serban MC, Antal D, Mikhailidis DP, Cicero A, Athyros V, Rizzo M, Rysz J, Banach M; Lipid and Blood Pressure Meta-analysis Collaboration Group. Lipid-modifying effects of krill oil in humans: systematic review and meta-analysis of randomized controlled trials. Nutr Rev 2017;75:361-73. [PMID: 28371906 DOI: 10.1093/nutrit/nuw063] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
77 Ciftci S, Caglar FNT, Biyik İ, Ungan I, Kural A, Sahin A, Akturk IF. Is there any association between vitamin D levels and isolated coronary artery ectasia? Arch Med Sci Atheroscler Dis 2016;1:e117-22. [PMID: 28905032 DOI: 10.5114/amsad.2016.63183] [Reference Citation Analysis]
78 Rosenson RS, Baker S, Banach M, Borow KM, Braun LT, Bruckert E, Brunham LR, Catapano AL, Elam MB, Mancini GJ, Moriarty PM, Morris PB, Muntner P, Ray KK, Stroes ES, Taylor BA, Taylor VH, Watts GF, Thompson PD. Optimizing Cholesterol Treatment in Patients With Muscle Complaints. Journal of the American College of Cardiology 2017;70:1290-301. [DOI: 10.1016/j.jacc.2017.07.752] [Cited by in Crossref: 137] [Cited by in F6Publishing: 144] [Article Influence: 27.4] [Reference Citation Analysis]
79 Cicero AFG, Colletti A, Bajraktari G, Descamps O, Djuric DM, Ezhov M, Fras Z, Katsiki N, Langlois M, Latkovskis G, Panagiotakos DB, Paragh G, Mikhailidis DP, Mitchenko O, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Ray KK, Rizzo M, Sahebkar A, Serban MC, Sperling LS, Toth PP, Vinereanu D, Vrablík M, Wong ND, Banach M. Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Arch Med Sci 2017;13:965-1005. [PMID: 28883839 DOI: 10.5114/aoms.2017.69326] [Cited by in Crossref: 169] [Cited by in F6Publishing: 184] [Article Influence: 33.8] [Reference Citation Analysis]
80 Sahebkar A, Simental-mendía LE, Reiner Ž, Kovanen PT, Simental-mendía M, Bianconi V, Pirro M. Effect of orlistat on plasma lipids and body weight: A systematic review and meta-analysis of 33 randomized controlled trials. Pharmacological Research 2017;122:53-65. [DOI: 10.1016/j.phrs.2017.05.022] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 9.8] [Reference Citation Analysis]
81 Sharma N, Cooper R, Kuh D, Shah I. Associations of statin use with motor performance and myalgia may be modified by 25-hydroxyvitamin D: findings from a British birth cohort. Sci Rep 2017;7:6578. [PMID: 28747665 DOI: 10.1038/s41598-017-06019-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
82 Ramachandran R, Wierzbicki AS. Statins, Muscle Disease and Mitochondria. J Clin Med 2017;6:E75. [PMID: 28757597 DOI: 10.3390/jcm6080075] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 10.0] [Reference Citation Analysis]
83 du Souich P, Roederer G, Dufour R. Myotoxicity of statins: Mechanism of action. Pharmacology & Therapeutics 2017;175:1-16. [DOI: 10.1016/j.pharmthera.2017.02.029] [Cited by in Crossref: 87] [Cited by in F6Publishing: 72] [Article Influence: 17.4] [Reference Citation Analysis]
84 Thompson PD, Panza G, Zaleski A, Taylor B. Statin-Associated Side Effects. J Am Coll Cardiol. 2016;67:2395-2410. [PMID: 27199064 DOI: 10.1016/j.jacc.2016.02.071] [Cited by in Crossref: 352] [Cited by in F6Publishing: 376] [Article Influence: 70.4] [Reference Citation Analysis]
85 Kang JH, Nguyen Q, Mutka J, Le QA. Authors’ Response. Journal of Pharmacy Practice 2017;30:386-387. [DOI: 10.1177/0897190017709810] [Reference Citation Analysis]
86 Rashidi B, Hoseini Z, Sahebkar A, Mirzaei H. Anti-Atherosclerotic Effects of Vitamins D and E in Suppression of Atherogenesis: ANTI-ATHEROSCLEROTIC EFFECTS OF VITAMINS D and E. J Cell Physiol 2017;232:2968-76. [DOI: 10.1002/jcp.25738] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 14.4] [Reference Citation Analysis]
87 Merel SE, Paauw DS. Common Drug Side Effects and Drug-Drug Interactions in Elderly Adults in Primary Care. J Am Geriatr Soc 2017;65:1578-85. [PMID: 28326532 DOI: 10.1111/jgs.14870] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
88 Calza L, Magistrelli E, Colangeli V, Borderi M, Contadini I, Bon I, Re MC, Viale P. Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients. AIDS 2017;31:681-8. [PMID: 28060020 DOI: 10.1097/QAD.0000000000001397] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
89 Dolezelova E, Stein E, Derosa G, Maffioli P, Nachtigal P, Sahebkar A. Effect of ezetimibe on plasma adipokines: a systematic review and meta-analysis. Br J Clin Pharmacol 2017;83:1380-96. [PMID: 28166606 DOI: 10.1111/bcp.13250] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
90 Bischoff-Ferrari HA, Fischer K, Orav EJ, Dawson-Hughes B, Meyer U, Chocano-Bedoya PO, Meyer OW, Ernst R, Schietzel S, Eberli F, Staehelin HB, Freystätter G, Roas S, Theiler R, Egli A, Wilson NM. Statin Use and 25-Hydroxyvitamin D Blood Level Response to Vitamin D Treatment of Older Adults. J Am Geriatr Soc 2017;65:1267-73. [PMID: 28240766 DOI: 10.1111/jgs.14784] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
91 Sahebkar A. Effects of quercetin supplementation on lipid profile: A systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr 2017;57:666-76. [PMID: 25897620 DOI: 10.1080/10408398.2014.948609] [Cited by in Crossref: 65] [Cited by in F6Publishing: 55] [Article Influence: 13.0] [Reference Citation Analysis]
92 Sahebkar A, Simental-Mendía LE, Watts GF, Serban MC, Banach M; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. Comparison of the effects of fibrates versus statins on plasma lipoprotein(a) concentrations: a systematic review and meta-analysis of head-to-head randomized controlled trials. BMC Med 2017;15:22. [PMID: 28153024 DOI: 10.1186/s12916-017-0787-7] [Cited by in Crossref: 40] [Cited by in F6Publishing: 50] [Article Influence: 8.0] [Reference Citation Analysis]
93 Ferretti G, Bacchetti T, Banach M, Simental-mendía LE, Sahebkar A. Impact of Statin Therapy on Plasma MMP-3, MMP-9, and TIMP-1 Concentrations: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. Angiology 2017;68:850-62. [DOI: 10.1177/0003319716688301] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
94 Backes JM, Ruisinger JF, Gibson CA, Moriarty PM. Statin-associated muscle symptoms—Managing the highly intolerant. Journal of Clinical Lipidology 2017;11:24-33. [DOI: 10.1016/j.jacl.2017.01.006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 6.6] [Reference Citation Analysis]
95 Antony B, Ding C. Vitamin D Deficiency in Joint Pain: Effects of Vitamin D Supplementation. Nutritional Modulators of Pain in the Aging Population 2017. [DOI: 10.1016/b978-0-12-805186-3.00015-1] [Reference Citation Analysis]
96 Banach M, Jankowski P, Jóźwiak J, Cybulska B, Windak A, Guzik T, Mamcarz A, Broncel M, Tomasik T, Rysz J, Jankowska-Zduńczyk A, Hoffman P, Mastalerz-Migas A. PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016. Arch Med Sci 2017;13:1-45. [PMID: 28144253 DOI: 10.5114/aoms.2017.64712] [Cited by in Crossref: 41] [Cited by in F6Publishing: 58] [Article Influence: 6.8] [Reference Citation Analysis]
97 Laufs U, Scharnagl H, Halle M, Windler E, Endres M, März W. Treatment Options for Statin-Associated Muscle Symptoms. Dtsch Arztebl Int 2015;112:748-55. [PMID: 26575138 DOI: 10.3238/arztebl.2015.0748] [Cited by in Crossref: 19] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
98 Sposito AC, Faria Neto JR, Carvalho LSFD, Lorenzatti A, Cafferata A, Elikir G, Esteban E, Morales Villegas EC, Bodanese LC, Alonso R, Ruiz AJ, Rocha VZ, Faludi AA, Xavier HT, Coelho OR, Assad MH, Izar MC, Santos RD, Fonseca FA, Mello e Silva A, Silva PMD, Bertolami MC. Statin-associated muscle symptoms: position paper from the Luso-Latin American Consortium. Current Medical Research and Opinion 2017;33:239-51. [DOI: 10.1080/03007995.2016.1252740] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
99 Katsiki N, Sahebkar A, Banach M. Vitamin D deficiency and metabolic syndrome: any link with statin intolerance and adipokines dysregulation? Clinical Lipidology 2016;11:23-24. [DOI: 10.1080/17584299.2016.1243651] [Reference Citation Analysis]
100 Kolovou V, Bilianou H, Kolovou G. Safe use of statins: focus on muscle toxicity. Clinical Lipidology 2016;11:16-22. [DOI: 10.1080/17584299.2016.1239873] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
101 Glueck CJ, Lee K, Prince M, Milgrom A, Makadia F, Wang P. Low serum vitamin D, statin associated muscle symptoms, vitamin D supplementation. Atherosclerosis 2017;256:125-7. [PMID: 28007301 DOI: 10.1016/j.atherosclerosis.2016.11.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
102 Taylor BA, Lorson L, White CM, Thompson PD. Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain. Atherosclerosis 2017;256:100-4. [PMID: 27993387 DOI: 10.1016/j.atherosclerosis.2016.11.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
103 Pereda CA, Nishishinya MB. Is There Really a Relationship Between Serum Vitamin D (25OHD) Levels and the Musculoskeletal Pain Associated With Statin Intake? A Systematic Review. Reumatología Clínica (English Edition) 2016;12:331-5. [DOI: 10.1016/j.reumae.2016.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
104 Kang JH, Nguyen QN, Mutka J, Le QA. Rechallenging Statin Therapy in Veterans With Statin-Induced Myopathy Post Vitamin D Replenishment. J Pharm Pract 2017;30:521-7. [PMID: 27798247 DOI: 10.1177/0897190016674407] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
105 Sahebkar A, Giua R, Pedone C. Impact of statin therapy on plasma leptin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials. Br J Clin Pharmacol 2016;82:1674-84. [PMID: 27509867 DOI: 10.1111/bcp.13086] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
106 Sahebkar A, Saboni N, Pirro M, Banach M. Curcumin: An effective adjunct in patients with statin-associated muscle symptoms? J Cachexia Sarcopenia Muscle 2017;8:19-24. [PMID: 27897416 DOI: 10.1002/jcsm.12140] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 6.7] [Reference Citation Analysis]
107 Ilinčić B, Stokić E, Stošić Z, Kojić NE, Katsiki N, Mikhailidis DP, Isenovic ER. Vitamin D status and circulating biomarkers of endothelial dysfunction and inflammation in non-diabetic obese individuals: a pilot study. Arch Med Sci 2017;13:53-60. [PMID: 28144255 DOI: 10.5114/aoms.2016.61812] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
108 Mikhailidis DP, Katsiki N, Athyros VG. Adherence to statin treatment: an important issue in clinical practice. Curr Med Res Opin 2016;32:1639-40. [PMID: 27357858 DOI: 10.1080/03007995.2016.1207621] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
109 Akbas EM, Gungor A, Ozcicek A, Akbas N, Askin S, Polat M. Vitamin D and inflammation: evaluation with neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio. Arch Med Sci 2016;12:721-7. [PMID: 27478451 DOI: 10.5114/aoms.2015.50625] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
110 Neřoldová M, Stránecký V, Hodaňová K, Hartmannová H, Piherová L, Přistoupilová A, Mrázová L, Vrablík M, Adámková V, Hubáček JA, Jirsa M, Kmoch S. Rare variants in known and novel candidate genes predisposing to statin-associated myopathy. Pharmacogenomics 2016;17:1405-14. [PMID: 27296017 DOI: 10.2217/pgs-2016-0071] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
111 Patel J, Martin SS, Banach M. Expert opinion: the therapeutic challenges faced by statin intolerance. Expert Opinion on Pharmacotherapy 2016;17:1497-507. [DOI: 10.1080/14656566.2016.1197202] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 5.7] [Reference Citation Analysis]
112 Coon SA, Ashjian EJ, Herink MC. Current Use of Statins for Primary Prevention of Cardiovascular Disease: Patient-Reported Outcomes and Adherence. Curr Cardiovasc Risk Rep 2016;10. [DOI: 10.1007/s12170-016-0504-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
113 Gluba-Brzozka A, Franczyk B, Toth PP, Rysz J, Banach M. Molecular mechanisms of statin intolerance. Arch Med Sci 2016;12:645-58. [PMID: 27279860 DOI: 10.5114/aoms.2016.59938] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 5.8] [Reference Citation Analysis]
114 Sahebkar A, Serban MC, Gluba-Brzózka A, Mikhailidis DP, Cicero AF, Rysz J, Banach M. Lipid-modifying effects of nutraceuticals: An evidence-based approach. Nutrition 2016;32:1179-92. [PMID: 27324061 DOI: 10.1016/j.nut.2016.04.007] [Cited by in Crossref: 120] [Cited by in F6Publishing: 132] [Article Influence: 20.0] [Reference Citation Analysis]
115 Pilz S, Verheyen N, Grübler MR, Tomaschitz A, März W. Vitamin D and cardiovascular disease prevention. Nat Rev Cardiol 2016;13:404-17. [PMID: 27150190 DOI: 10.1038/nrcardio.2016.73] [Cited by in Crossref: 191] [Cited by in F6Publishing: 197] [Article Influence: 31.8] [Reference Citation Analysis]
116 Fernandes V, Santos MJ, Pérez A. Statin-related myotoxicity. Endocrinología y Nutrición (English Edition) 2016;63:239-249. [DOI: 10.1016/j.endoen.2016.05.002] [Reference Citation Analysis]
117 Fernandes V, Santos MJ, Pérez A. Statin-related myotoxicity. Endocrinología y Nutrición 2016;63:239-49. [DOI: 10.1016/j.endonu.2016.01.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
118 Baque E, Sakzewski L, Barber L, Boyd RN. Systematic review of physiotherapy interventions to improve gross motor capacity and performance in children and adolescents with an acquired brain injury. Brain Inj 2016;30:948-59. [PMID: 27119733 DOI: 10.3109/02699052.2016.1147079] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
119 Jetty V, Glueck CJ, Wang P, Shah P, Prince M, Lee K, Goldenberg M, Kumar A. Safety of 50,000-100,000 Units of Vitamin D3/Week in Vitamin D-Deficient, Hypercholesterolemic Patients with Reversible Statin Intolerance. N Am J Med Sci 2016;8:156-62. [PMID: 27114973 DOI: 10.4103/1947-2714.179133] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
120 Pereda CA, Nishishinya MB. Is there really a relationship between serum vitamin D (25OHD) levels and the musculoskeletal pain associated with statin intake? A systematic review. Reumatol Clin 2016;12:331-5. [PMID: 27133556 DOI: 10.1016/j.reuma.2016.03.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
121 Whayne TF. Statin Intolerance From a Clinician’s Perspective. Angiology 2016;67:205-207. [DOI: 10.1177/0003319715587416] [Reference Citation Analysis]
122 Bays H, Kothari SN, Azagury DE, Morton JM, Nguyen NT, Jones PH, Jacobson TA, Cohen DE, Orringer C, Westman EC, Horn DB, Scinta W, Primack C. Lipids and bariatric procedures Part 2 of 2: scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA) 1. Surgery for Obesity and Related Diseases 2016;12:468-95. [DOI: 10.1016/j.soard.2016.01.007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
123 Latkovskis G, Saripo V, Sokolova E, Upite D, Vanaga I, Kletnieks U, Erglis A. Pilot study of safety and efficacy of polyprenols in combination with coenzyme Q10 in patients with statin-induced myopathy. Medicina 2016;52:171-9. [DOI: 10.1016/j.medici.2016.05.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
124 Banach M, Aronow WS, Serban MC, Rysz J, Voroneanu L, Covic A. Lipids, blood pressure and kidney update 2015. Lipids Health Dis 2015;14:167. [PMID: 26718096 DOI: 10.1186/s12944-015-0169-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 47] [Article Influence: 5.3] [Reference Citation Analysis]
125 Laufs U, Scharnagl H, März W. Statin intolerance: . Current Opinion in Lipidology 2015;26:492-501. [DOI: 10.1097/mol.0000000000000236] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
126 Minissian M, Agarwal M, Shufelt C, Mehta PK, Waldman T, Lentz G, Cook-Wiens G, Eastwood JA, Noel Bairey Merz C. Do women with statin-related myalgias have low vitamin D levels? BMC Res Notes 2015;8:449. [PMID: 26382747 DOI: 10.1186/s13104-015-1356-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
127 Manousopoulou A, Al-Daghri NM, Garbis SD, Chrousos GP. Vitamin D and cardiovascular risk among adults with obesity: a systematic review and meta-analysis. Eur J Clin Invest 2015;45:1113-26. [PMID: 26222607 DOI: 10.1111/eci.12510] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 6.6] [Reference Citation Analysis]
128 Banach M, Rizzo M, Toth PP, Farnier M, Davidson MH, Al-rasadi K, Aronow WS, Athyros V, Djuric DM, Ezhov MV, Greenfield RS, Hovingh GK, Kostner K, Serban C, Lighezan D, Fras Z, Moriarty PM, Muntner P, Goudev A, Ceska R, Nicholls SJ, Broncel M, Nikolic D, Pella D, Puri R, Rysz J, Wong ND, Bajnok L, Jones SR, Ray KK, Mikhailidis DP. Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel: This paper is also published in parallel in Archives of Medical Science [Banach M, Rizzo M, Toth PP, et al. Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Arch Med Sci 2015; 11(1): 1–23]. Expert Opinion on Drug Safety 2015;14:935-55. [DOI: 10.1517/14740338.2015.1039980] [Cited by in Crossref: 94] [Cited by in F6Publishing: 99] [Article Influence: 13.4] [Reference Citation Analysis]
129 Banach M, Aronow WS, Serban C, Sahabkar A, Rysz J, Voroneanu L, Covic A. Lipids, blood pressure and kidney update 2014. Pharmacol Res 2015;95-96:111-25. [PMID: 25819754 DOI: 10.1016/j.phrs.2015.03.009] [Cited by in Crossref: 61] [Cited by in F6Publishing: 73] [Article Influence: 8.7] [Reference Citation Analysis]
130 Agouridis AP, Nair DR, Mikhailidis DP. Strategies to overcome statin intolerance. Expert Opinion on Drug Metabolism & Toxicology 2015;11:851-5. [DOI: 10.1517/17425255.2015.1027685] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
131 Banach M, Rizzo M, Toth PP, Farnier M, Davidson MH, Al-Rasadi K, Aronow WS, Athyros V, Djuric DM, Ezhov MV, Greenfield RS, Hovingh GK, Kostner K, Serban C, Lighezan D, Fras Z, Moriarty PM, Muntner P, Goudev A, Ceska R, Nicholls SJ, Broncel M, Nikolic D, Pella D, Puri R, Rysz J, Wong ND, Bajnok L, Jones SR, Ray KK, Mikhailidis DP. Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Arch Med Sci 2015;11:1-23. [PMID: 25861286 DOI: 10.5114/aoms.2015.49807] [Cited by in Crossref: 234] [Cited by in F6Publishing: 268] [Article Influence: 33.4] [Reference Citation Analysis]
132 Banach M, Mikhailidis DP. In reply—Coenzyme Q10 and Statin-Induced Myopathy. Mayo Clinic Proceedings 2015;90:420-1. [DOI: 10.1016/j.mayocp.2015.01.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
133 Stroes ES, Thompson PD, Corsini A, Vladutiu GD, Raal FJ, Ray KK, Roden M, Stein E, Tokgözoğlu L, Nordestgaard BG, Bruckert E, De Backer G, Krauss RM, Laufs U, Santos RD, Hegele RA, Hovingh GK, Leiter LA, Mach F, März W, Newman CB, Wiklund O, Jacobson TA, Catapano AL, Chapman MJ, Ginsberg HN; European Atherosclerosis Society Consensus Panel. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur Heart J 2015;36:1012-22. [PMID: 25694464 DOI: 10.1093/eurheartj/ehv043] [Cited by in Crossref: 803] [Cited by in F6Publishing: 846] [Article Influence: 114.7] [Reference Citation Analysis]
134 Salinas D F, Universidad de Antioquia. Dolor músculo esquelético y vitamina D. Rev Col Med Fis Reh 2015;25:134-143. [DOI: 10.28957/rcmfr.v25n2a3] [Reference Citation Analysis]